Correlation Engine 2.0
Clear Search sequence regions

Sizes of these terms reflect their relevance to your search.

Malondialdehyde (MDA), a major lipid peroxidation product, spontaneously binds to, and modifies proteins. In vivo, proteins are physiologically exposed to micromolar MDA concentrations for long periods. In order to mimic this process in vitro, protein modification is often performed by short exposure to millimolar MDA concentrations, also in order to generate antigenic structures for antibody production. However, in our study, spectrophotometric and fluorimetric characteristics, electrophoretic migration, susceptibility to trypsin digestion and reactivity to antibodies indicated substantial differences between albumin incubated with millimolar MDA concentrations for a short period of time and albumin incubated with micromolar MDA concentrations for a long period of time. Therefore, our study showed that short incubation of albumin with millimolar MDA concentrations does not mimic the consequences of albumin exposure to long incubation with micromolar MDA concentrations. This casts doubts on the real possibility that antibodies, elicited with proteins modified with millimolar MDA concentrations for a short period, could detect all MDA-modified proteins in vivo. Moreover, natural antibodies against albumin, modified with micromolar MDA concentrations, have been detected in the serum of healthy blood donors, which appears to justify the existence of these kinds of modified proteins in vivo. Copyright © 2012 Elsevier Inc. All rights reserved.


Susanna Millanta, Anna Lisa Furfaro, Paolo Carlier, Bruno Tasso, Mariapaola Nitti, Cinzia Domenicotti, Patrizio Odetti, Maria Adelaide Pronzato, Nicola Traverso. Short exposure of albumin to high concentrations of malondialdehyde does not mimic physiological conditions. Experimental and molecular pathology. 2013 Feb;94(1):270-6

Expand section icon Mesh Tags

Expand section icon Substances

PMID: 22771309

View Full Text